112例原发性高血压的临床治疗效果分析

Analysis of the Clinical Treatment of 112 Patients with Primary Hypertension

目的探讨分析药物苯磺酸左旋氨氯地平在降低原发性高血压的临床治疗效果。方法将该院收治的高血压患者230例患者随机分成治疗组(112例)和对照组(118例),治疗组患者运用药物苯磺酸左旋氨氯地平,对照组患者运用硝苯地平缓释片组,均每2周为1个疗程。观察两组的血压变化情况和疗效。结果治疗组与对照组患者血压在服药以后和服药以前的降压作用对比,差异有统计学意义(P<0.01),但是两组间数据对比,差异无统计学意义(P>0.05)。治疗组患者的显效率为81.3%,总的有效率为91.9%;对照组患者的显效率为53.4%,总的有效率为81.4%。该两组患者的显效率对比,差异有统计学意义(P<0.05)。结论药物苯磺酸左旋氨氯地平属于一种安全高效的抗高血压药物,对于治疗原发性高血压有较高的治疗效果,值得临床推广。

Objective To study the clinical effects of Levamlodipine besylate on primary hypertension. Methods 230 patients with hypertension admitted in our hospital were divided into the treatment group （112 cases） and the control group （118 cases）randomly. The treatment group was treated with Levamlodipine besylate and the control group was treated with Nifedipine sustained release tablets. 2 weeks was a course of treatment in both groups. The changes of blood pressure and the efficacy of the groups were ob- served. Results There were statistically significant differences in the blood pressures of the treatment group and the control group before and after the treatment, respectively（P〈0.01）. There were no statistically significant differences in the data of blood pressure between the groups （P〉0.05）. The treatment group＇s markedly effective rate was 81.3%, total effective rate was 91.9%; while those of the control group was 53.4% and 81.4%, respectively. There was statistically difference in markedly effective rate between the groups （P〈0.05）. Conclusion Levamlodipine besylate is a safe and effective antihypertensive drug, and it has good effects on pri- mary hypertension, which is worthy of clinical promotion.